Effect of irbesarten on expression of CD 11b/CD 18 in patients with essential hypertension

覃宇果,倪海祥,邵国民,夏大静,秦南屏

DOI: https://doi.org/10.3969/j.issn.1006-2785.2003.07.007

2003-01-01

Abstract:Objective To instivate effect of irbesarten on the expression of CD 11b /CD 18 in patients with essential hypertension(EH)and the possible mechanismof irbesarten on renal protection.Methods Forty-nine patients of essential hypertension without clinical nephropaty and diabetes were randomly divided into irbesarten group(n=26)and amlodipine group(n=23).Levels of blood pressure,age,sex,duration of hypertension were matched at entry.The treatment course was3months.The main changes of blood pressure,urinary albumin exˉcretion rate(UAER),tumor necrosis factor-α(TNF-α)and the expression of CD 11b /CD 18 before and after treatment were observed.Results Levels of TNF-αand the expression of CD 11b /CD 18 in patients with EH were higher than those in normal controls.There were no significant differences in UAER,TNF-αand the expression of CD 11b /CD 18 between the irbesarten group and amlodipine group,but at the end of the3th months,the paˉrameters in irbesarten group were significantly lower than those in amlodipine group(P0.01).By correlation analysis,the decrement of UAER was positively correlated with the decrement of the levels of TNF-αand the expression of CD 11b /CD 18 (r=0.55,P0.01and r=0.64,P0.01).Conclusions(1)The expression of CD 11b /CD 18 and the levels of TNF-αincreased in patients with EH.(2)The renal protective effect of irbesarten is probably correlated with its inhibition on the expression of CD 11b /CD 18 in polymorphonuclear(PMN)leukoˉcytes.